KLSE (MYR): OPTIMAX (0222)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.64
Today's Change
-0.005 (0.78%)
Day's Change
0.64 - 0.65
Trading Volume
233,900
Market Cap
348 Million
NOSH
543 Million
Latest Quarter
30-Jun-2024 [#2]
Announcement Date
28-Aug-2024
Next Quarter
30-Sep-2024
Est. Ann. Date
29-Nov-2024
Est. Ann. Due Date
29-Nov-2024
QoQ | YoY
25.05% | -1.41%
Revenue | NP to SH
120,226.000 | 12,800.000
RPS | P/RPS
22.13 Cent | 2.89
EPS | P/E | EY
2.36 Cent | 27.17 | 3.68%
DPS | DY | Payout %
1.20 Cent | 1.88% | 50.55%
NAPS | P/NAPS
0.12 | 5.33
QoQ | YoY
-0.42% | -11.06%
NP Margin | ROE
11.90% | 19.63%
F.Y. | Ann. Date
30-Jun-2024 | 28-Aug-2024
Latest Audited Result
31-Dec-2023
Announcement Date
30-Apr-2024
Next Audited Result
31-Dec-2024
Est. Ann. Date
30-Apr-2025
Est. Ann. Due Date
29-Jun-2025
Revenue | NP to SH
113,953.000 | 12,891.000
RPS | P/RPS
20.97 Cent | 3.05
EPS | P/E | EY
2.37 Cent | 26.97 | 3.71%
DPS | DY | Payout %
1.19 Cent | 1.86% | 50.13%
NAPS | P/NAPS
0.12 | 5.38
YoY
-12.25%
NP Margin | ROE
12.53% | 19.95%
F.Y. | Ann. Date
31-Dec-2023 | 28-Feb-2024
Revenue | NP to SH
120,524.000 | 13,566.000
RPS | P/RPS
22.18 Cent | 2.89
EPS | P/E | EY
2.50 Cent | 25.63 | 3.90%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
12.52% | -1.32%
NP Margin | ROE
12.49% | 20.81%
F.Y. | Ann. Date
30-Jun-2024 | 28-Aug-2024
Trailing 4 Quarters | Trailing 8 Quarters | |||
---|---|---|---|---|
Available Quarters | 4 Quarters | 8 Quarters | ||
Continuous Quarters Of Revenue Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Total Positive Profit Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Profit Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Continuous Quarters Of Adjusted EPS Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Total Dividend Years | 2 / 4 | 50.00% | 4 / 8 | 50.00% |
Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Average ROE | 5.03% | 5.54% | ||
Average Net Profit Margin | 11.88% | 13.06% |
Last 5 Financial Years | Last 10 Financial Years | |||
---|---|---|---|---|
Available Years | 5 Years | 10 Years | ||
Continuous Quarters Of Revenue Growth | 3 / 5 | 60.00% | 3 / 5 | 60.00% |
Total Positive Profit Years | 5 / 5 | 100.00% | 5 / 5 | 100.00% |
Continuous Quarters Of Positive Profit | 5 / 5 | 100.00% | 5 / 5 | 100.00% |
Continuous Quarters Of Profit Growth | 0 / 5 | 0.00% | 0 / 5 | 0.00% |
Continuous Quarters Of Adjusted EPS Growth | 0 / 5 | 0.00% | 0 / 5 | 0.00% |
Total Dividend Years | 3 / 5 | 60.00% | 3 / 5 | 60.00% |
Continuous Quarters Of Dividend | 3 / 5 | 60.00% | 3 / 5 | 60.00% |
Continuous Quarters Of Dividend Growth | 0 / 5 | 0.00% | 0 / 5 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 0 / 5 | 0.00% | 0 / 5 | 0.00% |
Average ROE | 16.23% | 16.23% | ||
Average Net Profit Margin | 13.49% | 13.49% |
T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
---|---|---|---|---|---|
Revenue | 120,226 | 120,524 | 113,953 | 86,306 | 86,306 |
NP to SH | 12,800 | 13,566 | 12,891 | 10,670 | 10,670 |
Dividend | 6,470 | 0 | 6,461 | 5,936 | 5,936 |
Adjusted EPS | 2.36 | 2.50 | 2.37 | 1.96 | 1.96 |
Adjusted DPS | 1.20 | 0.00 | 1.19 | 1.09 | 1.09 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
---|---|---|---|---|---|
Revenue | 13.58% | 14.87% | 11.62% | 6.62% | 10.82% |
NP to Owner | 25.05% | -1.41% | -1.32% | 17.78% | 10.89% |
Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Adjusted EPS | 25.45% | -1.94% | -1.20% | 17.57% | 10.48% |
Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 5.50% | 39.30% | 39.30% | 5.77% | 39.65% | 39.65% | 5.47% | 32.03% | 32.03% |
NP to Owner | -0.71% | 19.96% | 19.96% | 5.24% | 27.14% | 27.14% | -12.25% | 20.81% | 20.81% |
Dividend | 0.14% | 9.00% | 9.00% | 0.00% | 0.00% | 0.00% | -50.14% | 8.85% | 8.85% |
Adjusted EPS | -0.54% | 20.16% | 20.16% | 5.36% | 27.29% | 27.29% | -12.25% | 20.81% | 20.81% |
Adjusted DPS | 0.90% | 9.83% | 9.83% | 0.00% | 0.00% | 0.00% | -50.14% | 8.85% | 8.85% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
ROE Recovery in FY25F as Optimax Executes Its Expansion Plans
We reiterate Add, with a lower TP of RM0.84 (from RM1.11), based on GGM to better capture its medium-term profitability and growth trajectory.
2023-12-11 15:04
From CIMB reserach report
https://klse.i3investor.com/web/staticfile/view/524018
2023-12-11 15:05
RM1 need to wait another 2-3 years I guess with this kind of economy situation ..
2023-12-12 11:35
CIMB lower tp from 1.11 to 0.84, fair valuation lah.. 30% upside from current price
2023-12-12 12:06
long-term demand drivers for eye specialist services including Malaysia’s growing population size and demographic; prevalence of lifestyle diseases; lifestyle changes and rising affluence
2023-12-13 13:52
That day I pass by Setia Alam and I saw Optimax is building a huge building there?
The building size is look like a hospital size, may I know why Optimax need to build such a huge building like hospital?
I though normally Optimax outlet is just 2000 -4000 sqft size will do, why need a hospital?
2023-12-13 14:02
That is a Selgate hospital. Optimax Holdings has been appointed as an exclusive operator of eye care for all Selgate Healthcare centres.
2023-12-13 15:23
aiya, just a small small price retracement, it will continue to move up gradually and steadily
2023-12-15 12:44
People spend a lot of time in front of the screen nowadays, so eye healthcare business will keep growing one
2023-12-15 13:33
Go buy techbond 41cents
Go buy spring art 21 cents.
Let see before cny feb 10 who return the most.
4/1/24 8.50pm
2024-01-04 20:48
Is Optimax expanding to Atria shopping mall in Damansara Jaya (Petaling Jaya)? Not open yet, right?
2024-01-11 20:25
Optimax 60 cents
Buy call optimax if below 60 cents.if below again just buy.
Tp 72-75 cents.
4/3/24 12.05am
2024-03-04 00:04
OPTIMAX 买在低点,不赢很难. 投行给高目标价, 盘后筹码峰技术分析.
He said resistance has broken, TP= 0.68 - 0.70
https://www.youtube.com/watch?v=Giq-LZsV0IM&ab_channel=DoubleSwords%E5%8F%8C%E5%89%91%E8%AE%BA%E8%82%A1
2024-03-12 23:02
Im more earlier ask to prepare snap up.4 of march.the guy on 12/3/24.please read.its up again.
13/3/24 12.51pm
Optimax 60 cents
Buy call optimax if below 60 cents.if below again just buy.
Tp 72-75 cents.
4/3/24 12.05am
2024-03-13 12:51
I'm long on Optimax and now seeing how far Optimax can go. Certainly encouraging signs, and sharing my trade idea and entire trade plan here https://youtu.be/-a8xumcKCY4
2024-03-30 13:59
Posted by curiousq > 2 weeks ago | Report Abuse
OPTIMAX 买在低点,不赢很难. 投行给高目标价, 盘后筹码峰技术分析.
He said resistance has broken, TP= 0.68 - 0.70
https://www.youtube.com/watch?v=Giq-LZsV0IM&ab_channel=DoubleSwords%E5%8F%8C%E5%89%91%E8%AE%BA%E8%82%A1
He guessed correctly 😄
2024-04-02 16:08
These are great information I also want to share more about online games https://monopolygo.io/
2024-04-20 15:24
Offering aesthetic on top of eye care, good business sense, so just top up some :)
2024-06-13 14:59
Entry – RM-0.715 – RM0.720
Stop Loss – RM0.675
Target Price – RM0.730 – RM0.767
2024-08-02 15:15
Nieto9
Rest assured, tis company will continue to optimize its operational costs and seek strategic locations across Malaysia to set up more ambulatory care centres/satellite clinics to support its growth
2023-12-11 14:24